1009 related articles for article (PubMed ID: 8170529)
1. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
[TBL] [Abstract][Full Text] [Related]
2. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
[TBL] [Abstract][Full Text] [Related]
3. Quazepam versus triazolam in patients with sleep disorders: a double-blind study.
Mauri MC; Gianetti S; Pugnetti L; Altamura AC
Int J Clin Pharmacol Res; 1993; 13(3):173-7. PubMed ID: 7901174
[TBL] [Abstract][Full Text] [Related]
4. Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam.
Kales A; Bixler EO; Vela-Bueno A; Soldatos CR; Niklaus DE; Manfredi RL
Clin Pharmacol Ther; 1986 Oct; 40(4):378-86. PubMed ID: 3530586
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of an every-other-night regimen in insomniac patients: subjective hypnotic effectiveness of quazepam, triazolam, and placebo.
Scharf MB
J Clin Psychiatry; 1993 Jan; 54(1):33-8. PubMed ID: 8428895
[TBL] [Abstract][Full Text] [Related]
6. A comparative 25-night sleep laboratory study on the effects of quazepam and triazolam on chronic insomniacs.
Mamelak M; Csima A; Price V
J Clin Pharmacol; 1984; 24(2-3):65-75. PubMed ID: 6143767
[TBL] [Abstract][Full Text] [Related]
7. Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder.
Saletu-Zyhlarz G; Anderer P; Brandstätter N; Dantendorfer K; Gruber G; Mandl M; Ritter K; Zoghlami A; Saletu B
Neuropsychobiology; 2000; 41(3):139-48. PubMed ID: 10754428
[TBL] [Abstract][Full Text] [Related]
8. Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise.
Saletu B; Kindshofer G; Anderer P; Grünberger J
Int J Clin Pharmacol Res; 1987; 7(5):407-18. PubMed ID: 2889679
[TBL] [Abstract][Full Text] [Related]
9. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
Monti JM; Attali P; Monti D; Zipfel A; de la Giclais B; Morselli PL
Pharmacopsychiatry; 1994 Jul; 27(4):166-75. PubMed ID: 7972349
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients.
Mendels J
J Clin Psychiatry; 1994 Feb; 55(2):60-5. PubMed ID: 7915708
[TBL] [Abstract][Full Text] [Related]
11. Quazepam in the short-term treatment of insomnia in outpatients.
Aden GC; Thatcher C
J Clin Psychiatry; 1983 Dec; 44(12):454-6. PubMed ID: 6361006
[TBL] [Abstract][Full Text] [Related]
12. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
[TBL] [Abstract][Full Text] [Related]
13. Effects of quazepam and triazolam on the sleep of chronic insomniacs: a comparative 25-night sleep laboratory study.
Mamelak M; Csima A; Price V
Clin Neuropharmacol; 1985; 8 Suppl 1():S63-73. PubMed ID: 3837688
[No Abstract] [Full Text] [Related]
14. [Controlled clinical study on the effect of quazepam versus triazolam in patients with sleep disorders].
Altamura AC; Colacurcio F; Mauri MC; De Vanna M; Rigamonti R; Maj M; Veltro F; Pancheri P; Delle Chiaie R; Porta M
Minerva Psichiatr; 1989; 30(3):159-64. PubMed ID: 2691808
[TBL] [Abstract][Full Text] [Related]
15. Quazepam and flurazepam: long-term use and extended withdrawal.
Kales A; Bixler EO; Soldatos CR; Vela-Bueno A; Jacoby J; Kales JD
Clin Pharmacol Ther; 1982 Dec; 32(6):781-8. PubMed ID: 7140142
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.
Voderholzer U; Riemann D; Hornyak M; Backhaus J; Feige B; Berger M; Hohagen F
Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):117-23. PubMed ID: 11697572
[TBL] [Abstract][Full Text] [Related]
17. Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database.
Saletu B; Prause W; Anderer P; Mandl M; Aigner M; Mikova O; Saletu-Zyhlarz GM
Neuropsychobiology; 2005; 51(3):148-63. PubMed ID: 15838186
[TBL] [Abstract][Full Text] [Related]
18. Rebound insomnia: a critical review.
Gillin JC; Spinweber CL; Johnson LC
J Clin Psychopharmacol; 1989 Jun; 9(3):161-72. PubMed ID: 2567741
[TBL] [Abstract][Full Text] [Related]
19. Quazepam: hypnotic efficacy and side effects.
Kales A
Pharmacotherapy; 1990; 10(1):1-10; discussion 10-2. PubMed ID: 1969151
[TBL] [Abstract][Full Text] [Related]
20. Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping.
Saletu-Zyhlarz G; Saletu B; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):117-29. PubMed ID: 9313244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
